You just read:

For Treatment of Ulcerative Colitis (UC), Great Opportunity Exists for Vedolizumab in the U.S. and EU5 Market, Owing to its Novel Mechanism of Action and Promising Efficacy

News provided by

Decision Resources Group

Apr 21, 2014, 11:43 ET